Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review

References

• Abdelkader H, Alani AW, Alany RG. (2014). Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv 21:87–100
   PubMed Web of Science ®Google Scholar
• Abolmaali SS, Tamaddon AM, Farvadi FS, et al. (2011). Pharmaceutical nanoemulsions and their potential topical and transdermal applications. Iran J Pharm Sci 7:139–50
   Google Scholar
• Aboutaleb E, Noori M, Gandomi N, et al. (2012). Improved antimycobacterial activity of rifampin using solid-lipid nanoparticles. Int Nano Lett 2:1–8
   Google Scholar
• Acevedo-Morantes CY, Acevedo-Morantes MT, Suleiman-Rosado D, Ramírez-Vick JE. (2013). Evaluation of the cytotoxic effect of camptothecin solid-lipid nanoparticles on MCF7 cells. Drug Deliv 20:338–48
   PubMed Web of Science ®Google Scholar
• Agatonovic-Kustrin S, Glass BD, Wisch MH, Alany RG. (2003). Prediction of a stable microemulsion formulation for the oral delivery of a combination of antitubercular drugs using ANN methodology. Pharm Res 20:1760–5
   PubMed Web of Science ®Google Scholar
• Ahmad Z, Pandey R, Sharma S, Khuller G. (2006). Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Indian J Chest Dis Allied Sci 48:171–6
   PubMedGoogle Scholar
• Ahmed M, Ramadan W, Rambhu D, Shakeel F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Int J Pharm Sci 63:806–11
   Google Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. (2013). Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:102
   PubMed Web of Science ®Google Scholar
• Alam MI, Baboota S, Ahuja A, et al. (2013). Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv 20:247–51
   PubMed Web of Science ®Google Scholar
• Allen B, Mitchison D, Chan Y, et al. (1983). Amikacin in the treatment of pulmonary tuberculosis. Tubercle 64:111–18
   PubMedGoogle Scholar
• Anwekar H, Patel S, Singhai A. (2011). Liposome as drug carriers. Int J Pharm Life Sci 2:945–51
   Google Scholar
• Banyal S, Malik P, Tuli HS, Mukherjee TK. (2013). Advances in nanotechnology for diagnosis and treatment of tuberculosis. Curr Opin Pulmon Med 19:289–97
   PubMed Web of Science ®Google Scholar
• Barakat NS, Yassin AEB. (2006). In vitro characterization of carbamazepine-loaded precifac lipospheres. Drug Deliv 13:95–104
   PubMed Web of Science ®Google Scholar
• Barrow EL, Barrow WW, Quenelle DC, et al. (2007). Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice. Drug Deliv 14:119–27
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kaur IP. (2013). Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid-lipid nanoparticles. Int J Pharm 441:202–12
   PubMed Web of Science ®Google Scholar
• Bhardwaj A, Kumar L, Narang R, Murthy R. (2013). Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis. Artif Cells Nanomedicine Biotechnol 41:52–9
   PubMed Web of Science ®Google Scholar
• Bhatt P, Madhav S. (2011). A detailed review on nanoemulsion drug delivery system. Int J Pharm Sci Res 2:2292–8
   Google Scholar
• Bhattacharya D, Dwivedi VP, Das G. (2013). Revisiting immunotherapy in tuberculosis. J Mycobac Dis 4:e123
   Google Scholar
• Caceres NE, Harris NB, Wellehan JF, et al. (1997). Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J Bacteriol 179:5046–55
   PubMed Web of Science ®Google Scholar
• Cao F, Ding B, Sun M, et al. (2011). Lung-targeted delivery system of curcumin loaded gelatin microspheres. Drug Deliv 18:545–54
   PubMed Web of Science ®Google Scholar
• Cekié ND, Savić SD, Milić J, et al. (2007). Preparation and characterisation of phenytoin-loaded alginate and alginate-chitosan microparticles. Drug Deliv 14:483–90
   PubMed Web of Science ®Google Scholar
• Chandu VP, Arunachalam A, Jeganath S, et al. (2012). Niosomes: a novel drug delivery system. Int J Novel Trends Pharm Sci 2:25–31
   Google Scholar
• Chaudhary C, Garg T. (2015). Scaffolds: a novel carrier and potential wound healer. Crit Rev Ther Drug Carrier Syst 32:277–321
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Garg T, Murthy R, et al. (2015a). Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway. Int J Pharm 485:108–21
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Garg T, Murthy RS, et al. (2014). Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target 22:871–82
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Garg T, Rath G, et al. (2015b). Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.1000493
   PubMed Web of Science ®Google Scholar
• Chimote G, Banerjee R. (2010). In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis. J Biomed Mater Res B Appl Biomater 94:1–10
   PubMed Web of Science ®Google Scholar
• Chokshi RJ, Zia H, Sandhu HK, et al. (2007). Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution – pros and cons. Drug Deliv 14:33–45
   PubMed Web of Science ®Google Scholar
• Comoglu T, Gonul N, Dogan A, Basci N. (2008). Development and in vitro evaluation of pantoprazole-loaded microspheres. Drug Deliv 15:295–302
   PubMed Web of Science ®Google Scholar
• Dawson R, Condos R, Tse D, et al. (2009). Immunomodulation with recombinant interferon-γ1b in pulmonary tuberculosis. PLoS One 4:e6984
   PubMed Web of Science ®Google Scholar
• Denholm J, Street A, McBryde E, Eisen D. (2012). Management of tuberculosis. Lulu.com
   Google Scholar
• Deol P, Khuller G. (1997). Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta Gen Subjects 1334:161–72
   PubMed Web of Science ®Google Scholar
• Devarajan V, Ravichandran V. (2011). Nanoemulsions: as modified drug delivery tool. Int J Compr Pharm 2:1–6
   Google Scholar
• Diljyot K. (2012). Niosomes: a new approach to targeted drug delivery. Int J Pharm Phytopharmacol Res 2:53–9
   Google Scholar
• Doan T, Olivier J. (2009). Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Int J Pharm 382:61–6
   PubMed Web of Science ®Google Scholar
• Domingo M, Gil O, Serrano E, et al. (2009). Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells’ fragments: field-study with naturally Mycobacterium caprae-infected goats. Scand J Immunol 69:500–7
   PubMed Web of Science ®Google Scholar
• Dong Z, Xie S, Zhu L, et al. (2011). Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid-lipid nanopartices for oral delivery. Drug Deliv 18:441–50
   PubMed Web of Science ®Google Scholar
• Doshi M. (2011). Dendrimer and its application. Int J Pharm Sci Rev Res 7:104–11
   Google Scholar
• Dutt M, Khuller G. (2001). Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in poly (DL-lactide-co-glycolide) microparticles. J Antimicrob Chemother 47:829–35
   PubMed Web of Science ®Google Scholar
• Düzgüneş N, Flasher D, Reddy MV, et al. (1996). Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. Antimicrob Agents Chemother 40:2618–21
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Shakeel F. (2014). Comparative topical delivery of antifungal drug croconazole using liposome and micro-emulsion-based gel formulations. Drug Deliv 21:34–43
   PubMed Web of Science ®Google Scholar
• El-Ridy M, Mostafa D, Shehab A, et al. (2007). Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis. Int J Pharm 330:82–8
   PubMed Web of Science ®Google Scholar
• El-Ridy MS, Abdelbary A, Nasr EA, et al. (2011). Niosomal encapsulation of the antitubercular drug, pyrazinamide. Drug Dev Ind Pharm 37:1110–18
   PubMed Web of Science ®Google Scholar
• El-Ridy MS, Yehia SA, Kassem MA-E-M, et al. (2015). Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety. Drug Deliv 22:21–36
   PubMed Web of Science ®Google Scholar
• Elgart A, Cherniakov I, Aldouby Y, et al. (2012). Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds. Chem Phys Lipids 165:438–53
   PubMed Web of Science ®Google Scholar
• Feng F-F, Zhang D-R, Tian K-L, et al. (2011). Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension. Drug Deliv 18:265–71
   PubMed Web of Science ®Google Scholar
• Feng R, Zhang Z, Li Z, Huang G. (2014). Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Drug Deliv 21:185–92
   PubMed Web of Science ®Google Scholar
• Gagandeep Garg T, Malik B, Rath G, Goyal AK. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53:10–16
   PubMed Web of Science ®Google Scholar
• Gandhi M, Paralkar S, Sonule M, et al. (2014). Niosomes: novel drug delivery system. Int J Pure Appl Biosci 2:267–74
   Google Scholar
• Gangadharam P, Ashtekar DR, Flasher DL, Düzgüneş N. (1995). Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob Agents Chemother 39:725–30
   PubMed Web of Science ®Google Scholar
• Gao X-F, Yang Z-W, Li J. (2011). Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. Int J Infect Dis 15:e594–600
   PubMed Web of Science ®Google Scholar
• Garg T. (2014). Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.916715
   Web of Science ®Google Scholar
• Garg T, Bhandari S, Rath G, Goyal AK. (2015a). Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. J Drug Target. [Epub ahead of print]. doi: 10.3109/1061186x.2015.1029930
   Web of Science ®Google Scholar
• Garg T, Goyal AK. (2012). Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett 2:270–80
   Google Scholar
• Garg T, Goyal AK. (2014a). Biomaterial-based scaffolds – current status and future directions. Expert Opin Drug Deliv 11:767–89
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. (2014b). Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4:62–71
   Google Scholar
• Garg T, Goyal AK. (2014c). Medicated chewing gum: patient compliance oral drug delivery system. Drug Deliv Lett 4:72–8
   Google Scholar
• Garg T, Goyal AK, Arora S, Murthy R. (2012a). Development, optimization, evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2:251–61
   Google Scholar
• Garg T, Kumar A, Rath G, Goyal AK. (2014a). Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst 31:531–57
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2014b). Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst 31:331–64
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2014c). Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery. J Drug Target 23:202–21
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2015b). Colloidal drug delivery systems: current status and future directions. Crit Rev Ther Drug Carrier Syst 32:89–147
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Murthy RR, et al. (2015c). Current nanotechnological approaches for an effective delivery of bioactive drug molecules to overcome drug resistance tuberculosis. Curr Pharm Des 21:3076–89
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2015d). Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1008508
   Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2015e). Nanotechnological approaches for the effective management of psoriasis. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1037885
   Web of Science ®Google Scholar
• Garg T, Singh O, Arora S, Murthy R. (2012b). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29:1–63
   PubMed Web of Science ®Google Scholar
• Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30:369–409
   PubMed Web of Science ®Google Scholar
• Garud A, Singh D, Garud N. (2012). Solid-lipid nanoparticles (SLN): method, characterization and applications. Int Curr Pharm J 1:384–93
   Google Scholar
• Gaspar M, Cruz A, Penha A, et al. (2008). Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis. Int J Antimicrob Agents 31:37–45
   PubMed Web of Science ®Google Scholar
• Gaspar MM, Neves S, Portaels F, et al. (2000). Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. Antimicrob Agents Chemother 44:2424–30
   PubMed Web of Science ®Google Scholar
• Gopalkrishnan S, Chenthilnathan AN. (2012). A novel drug delivery device. Res J Pharm Biol Chem Sci 3:1090–8
   Google Scholar
• Goyal G, Garg T, Malik B, et al. (2013). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2013.855277
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst 31:89–119
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. (2014b). Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst 31:365–405
   PubMed Web of Science ®Google Scholar
• Guirado E, Amat I, Gil O, et al. (2006). Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice. Microbes Infect 8:1252–9
   PubMed Web of Science ®Google Scholar
• Guo X, Xing Y, Zhang X, et al. (2012). In vivo controlled release and prolonged antitumor effects of 2-methoxyestradiol solid-lipid nanoparticles incorporated into a thermosensitive hydrogel. Drug Deliv 19:188–93
   PubMed Web of Science ®Google Scholar
• Gupta P, Garg T, Tanmay M, Arora S. (2015). Polymeric drug-delivery systems: role in P-gp efflux system inhibition. Crit Rev Ther Drug Carrier Syst 32:247–75
   PubMed Web of Science ®Google Scholar
• Halperin A, Alexander S. (1989). Polymeric micelles: their relaxation kinetics. Macromolecules 22:2403–12
   Web of Science ®Google Scholar
• Hari BV, Chitra KP, Bhimavarapu R, et al. (2010). Novel technologies: a weapon against tuberculosis. Indian J Pharmacol 42:338–44
   PubMed Web of Science ®Google Scholar
• Hu L, Yang J, Liu W, Li L. (2011). Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability. Drug Deliv 18:90–5
   PubMed Web of Science ®Google Scholar
• Hussain T, Garg T, Goyal AK, Rath G. (2014). Biomedical applications of nanofiber scaffolds in tissue engineering. J Biomater Tissue Eng 4:600–23
   Web of Science ®Google Scholar
• Islan GA, Castro GR. (2014). Tailoring of alginate–gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa. Drug Deliv 21:615–26
   PubMed Web of Science ®Google Scholar
• Jain C, Vyas S, Dixit V. (2006). Niosomal system for delivery of rifampicin to lymphatics. Indian J Pharm Sci 68:575–8
   Google Scholar
• Jain V, Prasad V, Jadhav P, Mishra P. (2009). Preparation and performance evaluation of saquinavir laden cationic submicron emulsions. Drug Deliv 16:37–44
   PubMed Web of Science ®Google Scholar
• Jana S, Gandhi A, Sen KK, Basu SK. (2012). Dendrimers: synthesis, properties, biomedical and drug delivery applications. Am J Pharm Tech Res 2:32–55
   Google Scholar
• Jassal M, Bishai WR. (2009). Extensively drug-resistant tuberculosis. Lancet Infect Dis 9:19–30
   PubMed Web of Science ®Google Scholar
• Jawahar N, Meyyanathan S, Reddy G, Sood S. (2012). Solid-lipid nanoparticles for oral delivery of poorly soluble drugs. J Pharm Sci Res 4:1848–55
   Google Scholar
• Jeong YJ, Lee KS. (2008). Pulmonary tuberculosis: up-to-date imaging and management. Am J Roentgenol 191:834–44
   PubMed Web of Science ®Google Scholar
• Jia L-J, Zhang D-R, Li Z-Y, et al. (2010). Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug Deliv 17:11–18
   PubMed Web of Science ®Google Scholar
• Johal HS, Garg T, Rath G, Goyal AK. (2014). Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.928760
   PubMed Web of Science ®Google Scholar
• Jores K. (2004). Lipid nanodispersions as drug carrier systems-a physicochemical characterization. Wittenberg: Martin-Luther Universität Halle
   Google Scholar
• Joshi D, Garg T, Goyal AK, Rath G. (2014a). Advanced drug delivery approaches against periodontitis. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.935531
   Web of Science ®Google Scholar
• Joshi D, Garg T, Goyal AK, Rath G. (2014b). Development and characterization of novel medicated nanofibers against periodontitis. Curr Drug Deliv 12:1–5
   Web of Science ®Google Scholar
• Justo OR, Moraes AM. (2005). Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment. J Pharm Pharmacol 57:23–30
   PubMed Web of Science ®Google Scholar
• Justo OR, Moraes ÂM. (2003). Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation. Drug Deliv 10:201–7
   PubMed Web of Science ®Google Scholar
• Kalia V, Garg T, Rath G, Goyal AK. (2014). Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.984303
   PubMed Web of Science ®Google Scholar
• Kamble MS, Vaidya KK, Bhosale AV, Chaudhari PD. (2012). Solid-lipid nanoparticles and nanostructured lipid carriers – an overview. Int J Pharm Chem Biol Sci 2:681–91
   Google Scholar
• Kaur G, Garg T, Rath G, Goyal AK. (2015a). Archaeosomes: an excellent carrier for drug and cell delivery. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2015.1019653
   Web of Science ®Google Scholar
• Kaur G, Mehta SK. (2014). Probing location of anti-TB drugs loaded in Brij 96 microemulsions using thermoanalytical and photophysical approach. J Pharm Sci 103:937–44
   PubMed Web of Science ®Google Scholar
• Kaur M, Garg T, Narang RK. (2014a). A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.962745
   Web of Science ®Google Scholar
• Kaur M, Garg T, Rath G, Goyal AK. (2014b). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:49–88
   PubMed Web of Science ®Google Scholar
• Kaur M, Malik B, Garg T, et al. (2014c). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv 22:328–34
   PubMed Web of Science ®Google Scholar
• Kaur N, Garg T, Goyal AK, Rath G. (2014d). Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.963900
   PubMed Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, Goyal AK. (2015b). In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1012260
   Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, et al. (2014e). Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.993486
   PubMed Web of Science ®Google Scholar
• Kaur P, Garg T, Vaidya B, et al. (2014f). Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment. J Drug Target 23:275–86
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Goyal AK, Rath G. (2015). Development, optimization and evaluation ofelectrospun nanofibers: tool fortargeted vaginal delivery of antimicrobials against urinary tract infections. Curr Drug Deliv 22:328–34
   Web of Science ®Google Scholar
• Kaur R, Garg T, Rath G, Goyal AK. (2014g). Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst 31:495–530
   PubMed Web of Science ®Google Scholar
• Kaur V, Garg T, Rath G, Goyal AK. (2014h). Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target 22:859–70
   PubMed Web of Science ®Google Scholar
• Kochi A, Vareldzis B, Styblo K. (1993). Multidrug-resistant tuberculosis and its control. Res Microbiol 144:104–10
   PubMed Web of Science ®Google Scholar
• Kotta S, Khan AW, Ansari S, et al. (2015). Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv 22:455–66
   PubMed Web of Science ®Google Scholar
• Kulkarni PR, Yadav J, Vaidya KA. (2011). Liposomes: a novel drug delivery system. Int J Curr Pharm Res 3:10–18
   Google Scholar
• Kumar A, Garg T, Sarma GS, et al. (2015). Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design. Eur J Pharm Sci 70C:140–51
   Web of Science ®Google Scholar
• Kumar G, Sharma S, Shafiq N, et al. (2011). Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis. Drug Deliv 18:65–73
   PubMed Web of Science ®Google Scholar
• Kumar N, Kumar M. (2011). Nanotechnology: a focus on treatment of tuberculosis. Int J Drug Deliv 3:25–42
   Google Scholar
• Kumar PV, Asthana A, Dutta T, Jain NK. (2006). Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 14:546–56
   PubMed Web of Science ®Google Scholar
• Kumar S, Singh V. (2012). Nanoemulsification – a novel targeted drug delivery tool. J Drug Deliv Ther 2:40–5
   Google Scholar
• Labana S, Pandey R, Sharma S, Khuller G. (2002). Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes. Int J Antimicrob Agents 20:301–4
   PubMed Web of Science ®Google Scholar
• Leitzke S, Bucke W, Borner K, et al. (1998). Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection. Antimicrob Agents Chemother 42:459–61
   PubMed Web of Science ®Google Scholar
• Li X, Guo Q, Zheng X, et al. (2009). Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery. Drug Deliv 16:160–6
   PubMed Web of Science ®Google Scholar
• Liang Y, Wu X, Zhang J, et al. (2011). Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs. Scand J Immunol 74:42–6
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhong Z, Peng G, et al. (2009). Folate receptor mediated intracellular gene delivery using the charge changing solid-lipid nanoparticles. Drug Deliv 16:341–7
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang F, Qin L, et al. (2010). Polymeric micelles as a drug delivery system enhance cytotoxicity of vinorelbine through more intercellular accumulation. Drug Deliv 17:255–62
   PubMed Web of Science ®Google Scholar
• Luan J, Zhang D, Hao L, et al. (2013). Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release. Drug Deliv 20:324–30
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Mahajan MS, Nerkar PP, Agrawal A. (2014). Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting. Drug Deliv 21:148–54
   PubMed Web of Science ®Google Scholar
• Malik R, Garg T, Goyal AK, Rath G. (2014). Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target 23:109–24
   PubMed Web of Science ®Google Scholar
• Malik R, Garg T, Goyal AK, Rath G. (2015). Diacerein-loaded novel gastroretentive nanofiber system using PLLA: development and in vitro characterization. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.1000492
   PubMed Web of Science ®Google Scholar
• Mansoori M, Agrawal S, Jawade S, Khan M. (2012). A review on liposome. Int J Adv Res Pharm Biosci 2:453–64
   Google Scholar
• Maretti E, Rossi T, Bondi M, et al. (2014). Inhaled solid-lipid microparticles to target alveolar macrophages for tuberculosis. Int J Pharm 462:74–82
   PubMed Web of Science ®Google Scholar
• Masungi C, Temmerman S, van Vooren J-P, et al. (2002). Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis 185:513–20
   PubMed Web of Science ®Google Scholar
• Meena LS. (2010). Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J 277:2416–27
   PubMed Web of Science ®Google Scholar
• Mehta S, Kaur G, Bhasin K. (2007). Analysis of Tween based microemulsion in the presence of TB drug rifampicin. Colloids Surf B Biointerfaces 60:95–104
   PubMed Web of Science ®Google Scholar
• Mehta S, Kaur G, Bhasin K. (2008). Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters. Pharm Res 25:227–36
   PubMed Web of Science ®Google Scholar
• Mehta S, Kaur G, Bhasin K. (2010). Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies. J Pharm Sci 99:1896–911
   PubMed Web of Science ®Google Scholar
• Mehta SK, Jindal N, Kaur G. (2011). Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. Colloids Surf B Biointerfaces 87:173–9
   PubMed Web of Science ®Google Scholar
• Mikusová K, Slayden RA, Besra GS, Brennan PJ. (1995). Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 39:2484–9
   PubMed Web of Science ®Google Scholar
• Modgill V, Garg T, Goyal AK, Rath G. (2014). Transmucosal delivery of linagliptin for the treatment of type-2 diabetes mellitus by ultra-thin nanofibers. Curr Drug Deliv 12:323–32
   Web of Science ®Google Scholar
• Mohan A, Kumar DP, Harikrishna J. (2013). Newer anti-TB drugs and drug delivery systems. In: Muruganathan A, ed. Medicine update. New Delhi: Jaypee Brothers Medical Publishers (for The Association of Physicians of India), 388–92
   Google Scholar
• Momoh M, Kenechukwu F, Attama A. (2013). Formulation and evaluation of novel solid-lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Deliv 20:102–11
   PubMed Web of Science ®Google Scholar
• Moretton MA, Glisoni RJ, Chiappetta DA, Sosnik A. (2010). Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles. Colloids Surf B Biointerfaces 79:467–79
   PubMed Web of Science ®Google Scholar
• Morie A, Garg T, Goyal AK, Rath G. (2014). Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.927879
   PubMed Web of Science ®Google Scholar
• Morlock GP, Metchock B, Sikes D, et al. (2003). ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 47:3799–805
   PubMed Web of Science ®Google Scholar
•  Mostafa DM, Ammar NM, Abd El-Alim SH, El-Anssary AA. (2014). Transdermal microemulsions of Glycyrrhiza glabra L.: characterization, stability and evaluation of antioxidant potential. Drug Deliv 21:130–9
   PubMed Web of Science ®Google Scholar
• Mujoriya RZ, Dhamandeb K, Bodla R. (2011). Niosomal drug delivery systems – a review. Int J Appl Pharm 3:7–10
   Google Scholar
• Mullaicharam A, Murthy R. (2004). Lung accumulation of niosome-entrapped rifampicin following intravenous and intratracheal administration in the rat. J Drug Deliv Sci Technol 14:99–104
   Web of Science ®Google Scholar
• Mutalik S, Shetty PK, Kumar A, et al. (2014). Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers. Drug Deliv 21:44–54
   PubMed Web of Science ®Google Scholar
• Muttil P, Kaur J, Kumar K, et al. (2007). Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci 32:140–50
   PubMed Web of Science ®Google Scholar
• Nair R, Arun Kumar K, Badivaddin TM, Sevukarajan M. (2011). Formulation and evaluation of solid-lipid nanoparticles of water soluble drug: isoniazid. J Pharm Sci Res 3:1256–64
   Google Scholar
• Narang AS, Delmarre D, Gao D. (2007). Stable drug encapsulation in micelles and microemulsions. Int J Pharm 345:9–25
   PubMed Web of Science ®Google Scholar
• Nasr M, Taha I, Hathout RM. (2013). Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route. Drug Deliv 20:311–18
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Kim J-A, et al. (2008). Preparation and evaluation of fast dissolving ibuprofen-polyethylene glycol 6000 solid dispersions. Drug Deliv 15:355–64
   PubMed Web of Science ®Google Scholar
• Nikolaeva LG, Maystat TV, Pylypchuk VS, et al. (2008a). Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin. Cytokine 44:392–6
   PubMed Web of Science ®Google Scholar
• Nikolaeva LG, Maystat TV, Pylypchuk VS, et al. (2008b). Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS. Int J Immunopharmacol 8:845–51
   PubMed Web of Science ®Google Scholar
• Nikonenko B, Reddy VM, Bogatcheva E, et al. (2014). Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis. Antimicrob Agents Chemother 58:587–9
   PubMed Web of Science ®Google Scholar
• Nikumbh KV, Sevankar SG, Patil MP. (2015). Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen. Drug Deliv 22:509–15
   PubMed Web of Science ®Google Scholar
• Nimje N, Agarwal A, Saraogi GK, et al. (2009). Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Target 17:777–87
   PubMed Web of Science ®Google Scholar
• Madhav NVS, Saini A. (2011). Niosomes: a novel drug delivery system. Int J Res Pharm Chem 3:498–511
   Google Scholar
• O'Hara P, Hickey AJ. (2000). Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm Res 17:955–61
   PubMed Web of Science ®Google Scholar
• Ohashi K, Kabasawa T, Ozeki T, Okada H. (2009). One-step preparation of rifampicin/poly (lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J Control Release 135:19–24
   PubMed Web of Science ®Google Scholar
• Onoshita T, Shimizu Y, Yamaya N, et al. (2010). The behavior of PLGA microspheres containing rifampicin in alveolar macrophages. Colloids Surf B Biointerfaces 76:151–7
   PubMed Web of Science ®Google Scholar
• Pabreja S, Garg T, Rath G, Goyal AK. (2014). Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.966195
   PubMed Web of Science ®Google Scholar
• Paliwal SR, Paliwal R, Vyas SP. (2015). A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery. Drug Deliv 22:231–42
   PubMed Web of Science ®Google Scholar
• Pallerla SM, Prabhakar B. (2013). A review on solid-lipid nanoparticles. Int J Pharm Sci Rev Res 20:196–206
   Google Scholar
• Palmero D, Eiguchi K, Rendo P, et al. (1999). Phase II trial of recombinant interferon-α2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. Int J Tuberc Lung Dis 3:214–18
   PubMed Web of Science ®Google Scholar
• Palomino JC, Martin A. (2014). Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics 3:317–40
   Google Scholar
• Pandey R, Khuller G. (2006a). Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model. J Antimicrob Chemother 57:1146–52
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller GK. (2006b). Nanoparticle-based oral drug delivery system for an injectable antibiotic-streptomycin. Evaluation in a murine tuberculosis model. Chemotherapy 53:437–41
   Web of Science ®Google Scholar
• Pandey R, Sharma S, Khuller G. (2004). Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs. Indian J Exp Biol 42:562–6
   PubMedGoogle Scholar
• Pandey R, Sharma S, Khuller G. (2005). Oral solid-lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis 85:415–20
   PubMed Web of Science ®Google Scholar
• Pandey V, Gajbhiye KR, Soni V. (2015). Lactoferrin-appended solid-lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma. Drug Deliv 22:199–205
   PubMed Web of Science ®Google Scholar
• Pardeshi CV, Rajput PV, Belgamwar VS, et al. (2013). Novel surface modified solid-lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach. Drug Deliv 20:47–56
   PubMed Web of Science ®Google Scholar
• Parhi R, Suresh P. (2012). Preparation and characterization of solid-lipid nanoparticles – a review. Curr Drug Discov Technol 9:2–16
   PubMedGoogle Scholar
• Parikh R, Patel L, Dalwadi S. (2014). Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats. Drug Deliv 21:406–11
   PubMed Web of Science ®Google Scholar
• Patel M, Shah A, Patel N, et al. (2011). Nanosuspension: a novel approach for drug delivery system. J Pharm Sci Biosci Res 1:1–10
   PubMedGoogle Scholar
• Patel N, Panda S. (2012). Liposome drug delivery system: a critic review. J Pharm Sci Biosci Res 2:162–94
   Google Scholar
• Patidar A, Thakur DS, Kumar P, Verma J. (2010). A review on novel lipid based nanocarriers. Int J Pharm Pharm Sci 2:30–5
   Google Scholar
• Patil U, Jaydeokar A, Bandawane D. (2012). Immunomodulators: a pharmacological review. Int J Pharm Pharm Sci 4:30–6
   Google Scholar
• Peters K, Leitzke S, Diederichs J, et al. (2000). Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother 45:77–83
   PubMed Web of Science ®Google Scholar
• Petersen EJ, Zhang L, Mattison NT, et al. (2011). Potential release pathways, environmental fate, and ecological risks of carbon nanotubes. Environ Sci Technol 45:9837–56
   PubMed Web of Science ®Google Scholar
• Pourshahab PS, Gilani K, Moazeni E, et al. (2011). Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid. J Microencapsul 28:605–13
   PubMed Web of Science ®Google Scholar
• Prasad R. (2007). Management of multi-drug resistant tuberculosis: practitioner's view point. Indian J Tuberc 54:3–11
   PubMedGoogle Scholar
• Pravinagurjar N, Chouksey S. (2014). Niosome: a promising pharmaceutical drug delivery. Int J Pharm Drug Anal 2:425–31
   Google Scholar
• Prihoda N, Arjanova OV, Yurchenko LV, et al. (2009). Adjuvant immunotherapy of extensively drug-resistant tuberculosis (XDR-TB) in Ukraine. Curr Res Tuberc 1:1–6
   Google Scholar
• Rahman S, Cao S, Steadman KJ, et al. (2012). Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer. Drug Deliv 19:346–53
   PubMed Web of Science ®Google Scholar
• Rana P, Murthy R. (2013). Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism. Drug Deliv 20:224–35
   PubMed Web of Science ®Google Scholar
• Rawat M, Singh D, Saraf S, Saraf S. (2008). Lipid carriers: a versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi 128:269–80
   PubMed Web of Science ®Google Scholar
• Reljic R, Ivanyi J. (2012). Immunotherapy of tuberculosis with IgA and cytokines, Croatia: INTECH Open Access Publisher
   Google Scholar
• Reverchon E, de Marco I, della Porta G. (2002). Rifampicin microparticles production by supercritical antisolvent precipitation. Int J Pharm 243:83–91
   PubMed Web of Science ®Google Scholar
• Ricci M, Giovagnoli S, Blasi P, et al. (2006). Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation. Int J Pharm 311:172–81
   PubMed Web of Science ®Google Scholar
• Rohilla R, Garg T, Bariwal J, et al. (2014a). Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.977460
   Web of Science ®Google Scholar
• Rohilla R, Garg T, Goyal AK, Rath G. (2014b). Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2014.945018
   Web of Science ®Google Scholar
• Rojanarat W, Nakpheng T, Thawithong E, et al. (2012). Inhaled pyrazinamide proliposome for targeting alveolar macrophages. Drug Deliv 19:334–45
   PubMed Web of Science ®Google Scholar
• Rosada RS, Torre LG, Frantz FG, et al. (2008). Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol 9:38
   PubMed Web of Science ®Google Scholar
• Salome AC, Ikechukwu VO. (2013). Lipid-based drug delivery systems (LDDS): Recent advances and applications of lipids in drug delivery. Afr J Pharm Pharmacol 7:3034–59
   Google Scholar
• Sankhyan A, Pawar P. (2012). Recent trends in niosome as vesicular drug delivery system. J Appl Pharm Sci 2:20–32
   Google Scholar
• Saraogi GK, Sharma B, Joshi B, et al. (2011). Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis. J Drug Target 19:219–27
   PubMed Web of Science ®Google Scholar
• Sarkar S, Suresh MR. (2011). An overview of tuberculosis chemotherapy – a literature review. J Pharm Pharm Sci 14:148–61
   PubMed Web of Science ®Google Scholar
• Sensi P. (1983). History of the development of rifampin. Rev Infect Dis 5:S402–6
   PubMedGoogle Scholar
• Setya S, Talegaonkar S, Razdan B. (2013). Nanoemulsions: formulation methods and stability aspects. World J Pharm Pharm Sci 3:2214–28
   Google Scholar
• Seyfoddin A, Shaw J, Al-Kassas R. (2010). Solid-lipid nanoparticles for ocular drug delivery. Drug Deliv 17:467–89
   PubMed Web of Science ®Google Scholar
• Sharma A, Garg T, Aman A, et al. (2014a). Nanogel – an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.930745
   Web of Science ®Google Scholar
• Sharma AK, Garg T, Goyal AK, Rath G. (2015). Role of microemuslsions in advanced drug delivery. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1012261
   Web of Science ®Google Scholar
• Sharma R, Garg T, Goyal AK, Rath G. (2014b). Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi:10.3109/21691401.2014.966194
   Web of Science ®Google Scholar
• Sharma R, Mahatma R, Bharkatiya M, Goyal A. (2012). Niosomes – as potential drug delivery system. Int J Drug Res Technol 2:422–9
   Google Scholar
• Sharma R, Saxena D, Dwivedi AK, Misra A. (2001). Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res 18:1405–10
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang J, Shen Y, et al. (2015). Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery. Drug Deliv 22:168–81
   PubMed Web of Science ®Google Scholar
• Singh B, Garg T, Goyal AK, Rath G. (2014a). Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2014.937868
   Web of Science ®Google Scholar
• Singh G, Dwivedi H, Saraf SK, Saraf SA. (2011). Niosomal delivery of isoniazid-development and characterization. Trop J Pharm Res 10:203–10
   Web of Science ®Google Scholar
• Singh G, Pai RS. (2014). Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine. Drug Deliv 21:627–35
   PubMed Web of Science ®Google Scholar
• Singh H, Bhandari R, Kaur IP. (2013). Encapsulation of Rifampicin in a solid-lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH. Int J Pharm 446:106–11
   PubMed Web of Science ®Google Scholar
• Singh K, Arora N, Garg T. (2012). Superbug: antimicrobial resistance due to NDM-1. Int J Inst Pharm Life Sci 2:58–66
   Google Scholar
• Singh O, Garg T, Rath G, Goyal AK. (2014b). Microbicides for the treatment of sexually transmitted HIV infections. J Pharm. [Epub ahead of print]. doi: 10.1155/2014/352425
   Google Scholar
• Smith JP. (2011). Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis. Yale J Biol Med 84:361–9
   PubMedGoogle Scholar
• Song X, Lin Q, Guo L, et al. (2015). Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Pharm Res 32:1741–51
   PubMed Web of Science ®Google Scholar
• Suarez S, O'Hara P, Kazantseva M, et al. (2001). Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother 48:431–4
   PubMed Web of Science ®Google Scholar
• Sung JC, Padilla DJ, Garcia-Contreras L, et al. (2009). Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res 26:1847–55
   PubMed Web of Science ®Google Scholar
• Swathi G, Prasanthi N, Manikiran S, Ramarao N. (2012). Solid-lipid nanoparticles: colloidal carrier systems for drug delivery. ChemInform 43:1–15
   Google Scholar
• Takenaga M, Ohta Y, Tokura Y, et al. (2008). Lipid microsphere formulation containing rifampicin targets alveolar macrophages. Drug Deliv 15:169–75
   PubMed Web of Science ®Google Scholar
• Thakare V, Nayak U, Lacchiramka P. (2012). Newer drugs for multi drug resistant tuberculosis and special emphasis on linezolid. Biol Sci 2:37–46
   Google Scholar
• Thakur A, Walia MK, Kumar S. (2013). Nanoemulsion in enhancement of bioavailability of poorly soluble drugs: a review. Pharmacophore 4:15–25
   Google Scholar
• Thomas TP, Shukla R, Kotlyar A, et al. (2008). Dendrimer − epidermal growth factor conjugate displays superagonist activity. Biomacromolecules 9:603–9
   PubMed Web of Science ®Google Scholar
• Thulasiramaraju T, Babu AS, Arunachalam A, et al. (2012). Liposomes: a novel drug delivery system. Int J Curr Pharm Res 3:10–18
   Google Scholar
• Utreja P, Jain S, Tiwary A. (2011). Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation. Drug Deliv 18:367–76
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Faghihian H, Rastgoo K. (2006). Preparation and characterization of metoprolol controlled-release solid dispersions. Drug Deliv 13:295–302
   PubMed Web of Science ®Google Scholar
• Verma RK, Kaur J, Kumar K, et al. (2008). Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice. Antimicrob Agents Chemother 52:3195–201
   PubMed Web of Science ®Google Scholar
• Vijayaraj Kumar P, Agashe H, Dutta T, Jain NK. (2007). PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Deliv 4:11–19
   PubMedGoogle Scholar
• Wade MM, Zhang Y. (2004). Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci 9:975–94
   PubMed Web of Science ®Google Scholar
• Wallis RS, Johnson JL. (2009). Immunotherapy of tuberculosis. In: Schaaf HS, Zumla A, eds. Tuberculosis. A comprehensive clinical reference. 1st ed. London: Saunders, Elsevier, 718–26
   Google Scholar
• Wang J, Xia Q. (2014). Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro. Drug Deliv 21:328–41
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng H, Zhou K, et al. (2013). Nanostructured lipid carriers as a delivery system of biochanin A. Drug Deliv 20:331–7
   PubMed Web of Science ®Google Scholar
• Wang S, Yang R, Yao H, et al. (2009). In vivo lymphatic targeting of methylene blue with microemulsion and multiple microemulsion. Drug Deliv 16:371–7
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu W. (2006). In situ evading of phagocytic uptake of stealth solid-lipid nanoparticles by mouse peritoneal macrophages. Drug Deliv 13:189–92
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Z, Zhang D, et al. (2015). Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery. Drug Deliv 22:79–85
   PubMed Web of Science ®Google Scholar
• Weber S, Zimmer A, Pardeike J. (2014). Solid-lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm 86:7–22
   PubMed Web of Science ®Google Scholar
• Yang L, Han J. (2000). Electronic structure of deformed carbon nanotubes. Phys Rev Lett 85:154–62
   PubMed Web of Science ®Google Scholar
• Yashodhara B, Huat CB, Naik LN, et al. (2010). Multidrug and extensively drug-resistant tuberculosis from a general practice perspective. Infect Drug Resist 3:115–22
   PubMedGoogle Scholar
• Zahoor A, Sharma S, Khuller G. (2005). Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 26:298–303
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu J, Wang Y, et al. (2012). Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis. Sci China Life Sci 55:800–6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wade MM, Scorpio A, et al. (2003). Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52:790–5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yew W. (2009). Mechanisms of drug resistance in Mycobacterium tuberculosis. In: Chiang CY, ed. State of the art series. Drug-resistant tuberculosis. Number 1 in the series. Int J Tuberc Lung Dis 13:1320–30
   Google Scholar
• Zheng D, Dai W, Zhang D, et al. (2012). In vivo studies on the oridonin-loaded nanostructured lipid carriers. Drug Deliv 19:286–91
   PubMed Web of Science ®Google Scholar
• Zumla A, Raviglione M, Hafner R, von Reyn CF. (2013). Current concepts. N Engl J Med 368:745–55
   PubMed Web of Science ®Google Scholar